{
  "slug": "b-12",
  "name": "b-12",
  "yc_id": 30689,
  "batch": "Summer 2025",
  "website": "https://b12-labs.com/",
  "web_data": {
    "web_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T01:40:09.411455",
    "website": "https://b12-labs.com/",
    "website_status": {
      "reachable": true,
      "status_code": 200,
      "response_time_ms": 2964.0,
      "final_url": "https://b12-labs.com/",
      "redirected": false,
      "checked_at": "2025-10-17T01:40:12.375473"
    },
    "ssl_security": {
      "disabled": true,
      "reason": "certificate_verification_failed"
    },
    "domain_info": {
      "domain": "b12-labs.com",
      "registrar": "GoDaddy.com, LLC",
      "creation_date": "2025-06-30T09:07:47",
      "expiration_date": "2027-06-30T09:07:47",
      "domain_age_days": 108,
      "domain_age_years": 0.3,
      "name_servers": [
        "NS21.DOMAINCONTROL.COM",
        "NS22.DOMAINCONTROL.COM"
      ]
    },
    "social_links": {
      "twitter": null,
      "linkedin": "https://www.linkedin.com/company/108178057",
      "github": null,
      "facebook": null,
      "instagram": null,
      "youtube": null
    },
    "security_headers": {
      "strict_transport_security": true,
      "content_security_policy": false,
      "x_frame_options": false,
      "x_content_type_options": true,
      "x_xss_protection": false,
      "referrer_policy": false,
      "security_score": 33,
      "server": "Framer/56b5dd6"
    }
  },
  "enrichment_version": "1.0.0",
  "enriched_at": "2025-10-17T10:39:24.456840",
  "phase1_complete": true,
  "phase2_complete": false,
  "phase3_complete": false,
  "phase4_complete": false,
  "phase5_complete": false,
  "ai_insights": {
    "ai_insights_version": "1.0.0",
    "model_used": "claude-sonnet-4-20250514",
    "enriched_at": "2025-10-17T11:40:19.392102",
    "status": "success",
    "market_analysis": {
      "market_size": "very large",
      "market_stage": "growing",
      "key_trends": [
        "AI-driven drug discovery acceleration",
        "Increased R&D efficiency demands in pharma",
        "Integration of robotics and automation in labs"
      ]
    },
    "competitive_positioning": {
      "competitive_moat": "Deep technical expertise with published Nature research and autonomous lab integration capabilities",
      "differentiation": "End-to-end AI copilot combining molecular design with autonomous robotic testing",
      "competitive_advantages": [
        "Proven academic credentials with 750+ citations",
        "Autonomous robotic lab integration",
        "Focus on actionable chemical recipes vs just predictions"
      ],
      "competitive_vulnerabilities": [
        "Early stage with limited market validation",
        "Dependence on robotic lab infrastructure adoption"
      ]
    },
    "business_model": {
      "revenue_model": "SaaS",
      "scalability": "high",
      "capital_intensity": "medium"
    },
    "growth_assessment": {
      "growth_stage": "pre-seed",
      "growth_indicators": [
        "Strong academic foundation",
        "Clear value proposition for pharma R&D",
        "YC backing and validation"
      ],
      "growth_bottlenecks": [
        "Customer acquisition in conservative pharma industry",
        "Integration complexity with existing lab workflows"
      ]
    },
    "risk_analysis": {
      "market_risk": "medium",
      "technology_risk": "medium",
      "execution_risk": "high",
      "overall_risk_score": 6,
      "key_risks": [
        "Long pharma sales cycles",
        "Regulatory compliance requirements",
        "Competition from established players like Schr\u00f6dinger"
      ]
    },
    "investment_thesis": {
      "strengths": [
        "World-class technical team with proven research",
        "Massive addressable market in drug discovery",
        "Clear time-to-value proposition"
      ],
      "concerns": [
        "Very early stage with limited commercial traction",
        "Complex enterprise sales process"
      ],
      "exit_potential": "acquisition",
      "comparable_companies": [
        "Schr\u00f6dinger",
        "Recursion Pharmaceuticals"
      ]
    },
    "recommendations": {
      "next_steps": [
        "Secure pilot customers from mid-tier biotech companies",
        "Develop case studies demonstrating ROI and time savings"
      ],
      "expansion_opportunities": [
        "Adjacent markets like agrochemicals",
        "International expansion to European pharma hubs"
      ]
    },
    "tokens_used": {
      "input": 749,
      "output": 575,
      "total": 1324,
      "estimated_cost": 0.010872
    }
  },
  "phase8_complete": true
}